Home Cart 0 Sign in  

[ CAS No. 768-05-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 768-05-8
Chemical Structure| 768-05-8
Structure of 768-05-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 768-05-8 ]

Related Doc. of [ 768-05-8 ]

Alternatived Products of [ 768-05-8 ]

Product Details of [ 768-05-8 ]

CAS No. :768-05-8 MDL No. :MFCD00778762
Formula : C5H6N4O Boiling Point : -
Linear Structure Formula :- InChI Key :OHFIJHDYYOCZME-UHFFFAOYSA-N
M.W : 138.13 Pubchem ID :258796
Synonyms :

Calculated chemistry of [ 768-05-8 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 32.93
TPSA : 80.9 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.82 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.7
Log Po/w (XLOGP3) : -0.95
Log Po/w (WLOGP) : -0.92
Log Po/w (MLOGP) : -1.68
Log Po/w (SILICOS-IT) : -0.69
Consensus Log Po/w : -0.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.41
Solubility : 53.8 mg/ml ; 0.389 mol/l
Class : Very soluble
Log S (Ali) : -0.26
Solubility : 75.2 mg/ml ; 0.544 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.26
Solubility : 7.5 mg/ml ; 0.0543 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.87

Safety of [ 768-05-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 768-05-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 768-05-8 ]
  • Downstream synthetic route of [ 768-05-8 ]

[ 768-05-8 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 6164-79-0 ]
  • [ 768-05-8 ]
YieldReaction ConditionsOperation in experiment
100% With hydrazine In ethanol for 2 h; Heating / reflux Pyrazine-2-carboxylic acid hydrazide. To a stirred solution of pyrazine-2-carboxylic acid methyl ester (11.1 g, 80 mmol) in 140 mL OF ETOH was added hydrazine hydrate (15.6 ML, 320 mmol). The resultant solution was heated to reflux for 2h. The solvent was removed under reduced pressure and dried under high vacuum to yield the title amide (11.1 g, 100percent) as a white solid. The product was used in subsequent steps without purification.
100% With hydrazine In ethanol for 2 h; Heating / reflux Example 261; 5-Phenyl-2-(3-pyrazin-2-yl-ureido)-thiophene-3-carboxylic acid (S)-azepan-3-ylamide pyrazine-2-carbohydrazide. ; To a stirred solution of methyl pyrazine-2-carboxylate (11.1 g, 80 mmol) in 140 mL of EtOH was added hydrazine hydrate (15.6 mL, 320 mmol). The resultant solution was heated to reflux for 2h. The solvent was removed under reduced pressure and dried under high vacuum to yield the title amide (11.1 g, 100percent) as a white solid. The product was used in subsequent steps without purification.'H NMR (d6-DMSO 8 10.1, br s, 1H; 8 9.12, d, 1H ; 8 8. 83, d, 1H ; 8 8.70, dd, 1H; 8 4.64, br s, 2H), LC/MS (APCI, ES, M+H=139).
75% With hydrazine hydrate In methanol for 5 h; Reflux General procedure: To a solution of an appropriate methyl esters17(a–j) (1.0 mmol) in 50 mL of methanol was added 99 percenthydrazine hydrate (4.0 mmol) and the mixture was refluxedfor 5 h up to reaction completed (TLC). After completionof reaction, it was allowed to cool and the obtained solidwas washed with methanol. The crude products wererecrystallized from ethanol.
68% at 78℃; Example 21.1Pyrazine-2-carbohydrazide To the title compound of Example 19.1 (1.28 mg, 9.3 mmol) in ethanol (10 mL) was added hydrazine hydrate (0.54 mL, 11.1 mmol) and then heated at 78° C. overnight. The reaction mixture was cooled and concentrated in vacuo. The residue was triturated with ethyl acetate, filtered and dried to give the title product as a yellow solid (870 mg, 68percent).1H NMR (300 MHz, (CD3)2SO): δ (ppm) 10.16 (broad s, 1H), 9.13 (s, 1H), 8.84 (s, 1H), 8.70 (s, 1H), 4.65 (broad s, 2H).
56% With hydrazine In tetrahydrofuran for 3 h; Reflux Methyl pyrazine-2-carboxylate (0.5g; 3.6mmol) was dissolved in THF (5mL), and 98percent hydrazine (0.53mL; 11mmol) was added. The mixture was refluxed for 3h and cooled to rt. The resulting solid was filtered off, washed with THF and dried over P2O5 to give 0.28g (56percent) of a white solid. Rf=0.53 (CHCl3/MeOH 10:1). mp 166–169°C (lit. 167–169°C) [64]. 1H NMR (300MHz, DMSO): δ 10.11 (s, 1H, NH), 9.12 (s, 1H, Ar), 8.82 (d, J=2.4Hz, 1H, Ar), 8.68 (d, J=2.4Hz, 1H, Ar), 4.65 (s, 2H, NH2). 13C NMR (75MHz, DMSO): δ 161.7, 147.4, 145.1, 143.7, 143.4.

Reference: [1] Patent: WO2005/16909, 2005, A1, . Location in patent: Page/Page column 73
[2] Patent: WO2005/66163, 2005, A2, . Location in patent: Page/Page column 128
[3] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 14, p. 5007 - 5015
[4] European Journal of Inorganic Chemistry, 2011, # 32, p. 5036 - 5042
[5] European Journal of Medicinal Chemistry, 2009, vol. 44, # 12, p. 4954 - 4959
[6] Letters in Drug Design and Discovery, 2010, vol. 7, # 4, p. 275 - 280
[7] Medicinal Chemistry, 2011, vol. 7, # 3, p. 245 - 249
[8] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[9] Patent: US2007/259862, 2007, A1, . Location in patent: Page/Page column 26
[10] Chemistry - A European Journal, 2018, vol. 24, # 39, p. 9928 - 9939
[11] Chemical Communications, 2012, vol. 48, # 5, p. 708 - 710
[12] Chemistry - A European Journal, 2012, vol. 18, # 2, p. 442 - 445
[13] European Journal of Medicinal Chemistry, 2016, vol. 120, p. 97 - 110
[14] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 22, p. 622
[15] Patent: US2149279, 1935, ,
[16] Journal of Medicinal Chemistry, 1989, vol. 32, # 11, p. 2474 - 2485
[17] Patent: US6297235, 2001, B1,
[18] European Journal of Medicinal Chemistry, 2010, vol. 45, # 8, p. 3384 - 3388
[19] Patent: WO2010/125102, 2010, A1, . Location in patent: Page/Page column 125-126
[20] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6356 - 6365
[21] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 90 - 95
[22] Dalton Transactions, 2017, vol. 46, # 30, p. 9875 - 9885
[23] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 907 - 917
[24] Chemical Research in Toxicology, 2018, vol. 31, # 6, p. 435 - 446
[25] Patent: US2149279, 1935, ,
  • 2
  • [ 6924-68-1 ]
  • [ 768-05-8 ]
YieldReaction ConditionsOperation in experiment
95% With hydrazine hydrate In ethanol for 6 h; Reflux General procedure: A mixture of the ester derivative 8a or 8b (5.5 mmol) and hydrazine hydrate (11 mmol) in 50 mL of ethanol was heated under reflux for 6 h. The reaction mixture was left overnight at room temperature, and the solid which separated was collected by filtration. The solid was then washed with ethanol, dried, and recrystallized from ethanol (Yoshino et al., 2006; Vlaovic et al., 1990).
Reference: [1] Medicinal Chemistry Research, 2015, vol. 24, # 6, p. 2529 - 2550
[2] European Journal of Medicinal Chemistry, 2012, vol. 47, # 1, p. 452 - 461
[3] Journal of the Chemical Society, Dalton Transactions, 2002, # 21, p. 4048 - 4054
[4] ChemMedChem, 2017, vol. 12, # 12, p. 972 - 985
  • 3
  • [ 98-96-4 ]
  • [ 768-05-8 ]
YieldReaction ConditionsOperation in experiment
80% With hydrazine hydrate In ethanol for 12 h; Reflux A mixture of pyrazine-2-carboxamide (1) 50 g (0.406 mol) in ethanol (500 mL) and hydrazine hydrate (98percent) 34.76 g (0.695 mol) was refluxed for 12 h. The completion of reaction was monitored by TLC (Hexane 6: Ethyl acetate 4). The reaction mass cooled to 10-15°C and filtered off under vacuum. Pyrazin-2-carboxamide is highly soluble in iso-octane at 25-30°C. Iso-octane (50 mL) washing given and suck dried to give pure white to off white solid compound (2) 41.50 g (80.00percent) mp-168-170°C. IR (KBr, cm-1): 3352.4 (-NH2 stretch), 3230.3 (>NH stretch), 2845 (-OCH3), 1640.65 (>C=O stretch), 764 (>C-Br); 1HNMR (400 MHz, DMSO-d6 ppm): δ 4.50 (s, 2H, amine), 8.59 (s, 1H, amide), 8.74 (d, 1H, CH-pyrazine), 9.16 (d, 1H, CH-pyrazine), 9.90 (s, 1H, C=NH); 13C NMR (400MHz, DMSO-d6 ppm): 143.36 (pyrazine C-N), 143.71 (pyrazine C=N), 144.74 (pyrazine C=N), 147.38 (pyrazine C=N), 162.10 (-C=O). MS: 137; m/z: 138 (M+H).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 16, p. 3845 - 3850
  • 4
  • [ 98-97-5 ]
  • [ 768-05-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 3, p. 817 - 821
[2] Journal of the Chemical Society, Dalton Transactions, 2002, # 21, p. 4048 - 4054
[3] Letters in Drug Design and Discovery, 2010, vol. 7, # 4, p. 275 - 280
[4] European Journal of Inorganic Chemistry, 2011, # 32, p. 5036 - 5042
[5] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 21, p. 6356 - 6365
[6] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 90 - 95
[7] Medicinal Chemistry Research, 2015, vol. 24, # 6, p. 2529 - 2550
[8] Medicinal Chemistry Research, 2016, vol. 25, # 4, p. 627 - 643
[9] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 9, p. 2224 - 2228
[10] ChemMedChem, 2017, vol. 12, # 12, p. 972 - 985
[11] Pharmaceutical Chemistry Journal, 2018, vol. 51, # 10, p. 907 - 917
[12] Journal of Molecular Structure, 2018, vol. 1164, p. 459 - 469
  • 5
  • [ 19847-10-0 ]
  • [ 768-05-8 ]
Reference: [1] Pakistan Journal of Scientific and Industrial Research, 1993, vol. 36, # 11, p. 466 - 467
  • 6
  • [ 103435-88-7 ]
  • [ 768-05-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 3, p. 817 - 821
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 768-05-8 ]

Amides

Chemical Structure| 6761-52-0

[ 6761-52-0 ]

3-Aminopyrazine-2-carbohydrazide

Similarity: 0.85

Chemical Structure| 848952-83-0

[ 848952-83-0 ]

5-Chloropyrazine-2-carboxylic acid hydrazide

Similarity: 0.80

Chemical Structure| 89323-09-1

[ 89323-09-1 ]

5-Aminopyrazine-2-carboxamide

Similarity: 0.76

Chemical Structure| 32587-10-3

[ 32587-10-3 ]

3-Aminopyrazine-2-carboxamide

Similarity: 0.74

Chemical Structure| 36070-84-5

[ 36070-84-5 ]

5-Bromopyrazine-2-carboxamide

Similarity: 0.72

Hydrazides

Chemical Structure| 6761-52-0

[ 6761-52-0 ]

3-Aminopyrazine-2-carbohydrazide

Similarity: 0.85

Chemical Structure| 848952-83-0

[ 848952-83-0 ]

5-Chloropyrazine-2-carboxylic acid hydrazide

Similarity: 0.80

Chemical Structure| 1452-63-7

[ 1452-63-7 ]

Picolinohydrazide

Similarity: 0.58

Chemical Structure| 553-53-7

[ 553-53-7 ]

(3-Pyridylcarbonyl)hydrazine

Similarity: 0.54

Chemical Structure| 39513-54-7

[ 39513-54-7 ]

Pyrimidine-4-carbohydrazide

Similarity: 0.54

Amines

Chemical Structure| 6761-52-0

[ 6761-52-0 ]

3-Aminopyrazine-2-carbohydrazide

Similarity: 0.85

Chemical Structure| 848952-83-0

[ 848952-83-0 ]

5-Chloropyrazine-2-carboxylic acid hydrazide

Similarity: 0.80

Chemical Structure| 89323-09-1

[ 89323-09-1 ]

5-Aminopyrazine-2-carboxamide

Similarity: 0.76

Chemical Structure| 32587-10-3

[ 32587-10-3 ]

3-Aminopyrazine-2-carboxamide

Similarity: 0.74

Chemical Structure| 36070-84-5

[ 36070-84-5 ]

5-Bromopyrazine-2-carboxamide

Similarity: 0.72

Hydrazines

Chemical Structure| 6761-52-0

[ 6761-52-0 ]

3-Aminopyrazine-2-carbohydrazide

Similarity: 0.85

Chemical Structure| 848952-83-0

[ 848952-83-0 ]

5-Chloropyrazine-2-carboxylic acid hydrazide

Similarity: 0.80

Chemical Structure| 1452-63-7

[ 1452-63-7 ]

Picolinohydrazide

Similarity: 0.58

Chemical Structure| 553-53-7

[ 553-53-7 ]

(3-Pyridylcarbonyl)hydrazine

Similarity: 0.54

Chemical Structure| 39513-54-7

[ 39513-54-7 ]

Pyrimidine-4-carbohydrazide

Similarity: 0.54

Related Parent Nucleus of
[ 768-05-8 ]

Pyrazines

Chemical Structure| 6761-52-0

[ 6761-52-0 ]

3-Aminopyrazine-2-carbohydrazide

Similarity: 0.85

Chemical Structure| 848952-83-0

[ 848952-83-0 ]

5-Chloropyrazine-2-carboxylic acid hydrazide

Similarity: 0.80

Chemical Structure| 89323-09-1

[ 89323-09-1 ]

5-Aminopyrazine-2-carboxamide

Similarity: 0.76

Chemical Structure| 32587-10-3

[ 32587-10-3 ]

3-Aminopyrazine-2-carboxamide

Similarity: 0.74

Chemical Structure| 36070-84-5

[ 36070-84-5 ]

5-Bromopyrazine-2-carboxamide

Similarity: 0.72